tiprankstipranks
Pharmarise Holdings Corp. (JP:2796)
:2796
Japanese Market
Want to see JP:2796 full AI Analyst Report?

Pharmarise Holdings Corp. (2796) Financial Statements

0 Followers

Pharmarise Holdings Corp. Financial Overview

Pharmarise Holdings Corp.'s market cap is currently ¥5.71B. The company's EPS TTM is ¥-22.36; its P/E ratio is 48.41; and it has a dividend yield of 2.65%. Pharmarise Holdings Corp. is scheduled to report earnings on June 25, 2026, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
May 25May 24May 23May 22May 21
Income Statement
Total Revenue¥ 69.51B¥ 63.51B¥ 54.47B¥ 52.03B¥ 51.61B
Gross Profit¥ 8.64B¥ 8.20B¥ 7.89B¥ 7.50B¥ 7.42B
Operating Income¥ 980.00M¥ 295.00M¥ 916.00M¥ 1.44B¥ 1.52B
EBITDA¥ 980.00M¥ 1.68B¥ 1.38B¥ 2.33B¥ 2.69B
Net Income¥ 113.00M¥ -368.00M¥ -351.00M¥ 333.00M¥ 448.00M
Balance Sheet
Cash & Short-Term Investments¥ 6.01B¥ 4.91B¥ 7.15B¥ 4.74B¥ 3.99B
Total Assets¥ 32.68B¥ 31.99B¥ 29.54B¥ 23.46B¥ 23.78B
Total Debt¥ 5.34B¥ 14.28B¥ 12.75B¥ 9.14B¥ 9.91B
Net Debt¥ -670.00M¥ 9.39B¥ 5.65B¥ 4.40B¥ 5.92B
Total Liabilities¥ 25.82B¥ 25.07B¥ 22.10B¥ 16.47B¥ 17.08B
Stockholders' Equity¥ 6.84B¥ 6.87B¥ 7.36B¥ 6.88B¥ 6.61B
Cash Flow
Free Cash Flow¥ 2.58B¥ 674.00M¥ 2.24B¥ 2.14B¥ 334.00M
Operating Cash Flow¥ 3.28B¥ 1.31B¥ 2.71B¥ 2.52B¥ 713.00M
Investing Cash Flow¥ -1.98B¥ -4.46B¥ -3.12B¥ -703.00M¥ -292.00M
Financing Cash Flow¥ -181.00M¥ 939.00M¥ 2.77B¥ -1.07B¥ -1.03B
Currency in JPY

Pharmarise Holdings Corp. Earnings and Revenue History

Pharmarise Holdings Corp. Debt to Assets

Pharmarise Holdings Corp. Cash Flow

Pharmarise Holdings Corp. Forecast EPS vs Actual EPS